What is Neuronetics Inc (STIM) stock price today?

Neuronetics Inc (STIM) currently trades at $1.94 per share. The stock has a market capitalization of $117.59M and a P/E ratio of —x.

Is STIM stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Neuronetics Inc has a Smart Value Score of 35/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Neuronetics Inc's revenue and earnings?

Neuronetics Inc has trailing twelve-month (TTM) revenue of $149.16M with profit margins of -26.20%. Earnings per share (EPS) is $-0.59.

Is STIM stock overvalued or undervalued?

Based on our DCF model, Neuronetics Inc's intrinsic value is $13.08, representing a margin of safety of 86.24%. The stock currently trades at a P/E of —x.

STIM

Neuronetics Inc

NASDAQ: STIM · HEALTHCARE · MEDICAL DEVICES

$1.94

+14.12% today

Updated 2026-04-30

Market cap

$117.59M

P/E ratio

—

P/S ratio

0.79x

EPS (TTM)

$-0.59

Dividend yield

—

52W range

$1 – $5

Volume

1.9M

Market cap

$117.59M

P/E ratio

—

P/S ratio

0.79x

EPS (TTM)

$-0.59

Dividend yield

—

52W range

$1 – $5

Volume

1.9M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

8.0

Growth

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$4.33

+123.35%

12-Month target

—

Intrinsic (DCF)

$13.08

Margin of safety

+86.24%

2 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $692000.00 — positive

+ Revenue growth 85.70% QoQ

+ 86.24% below intrinsic value

Risks

- Thin margins at -26.20%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$65.21M	$71.35M	$74.89M	$149.16M	$149.16M
Net income	$-37.16M	$-30.19M	$-43.71M	$-39.00M	$-7.16M
EPS	—	—	—	—	$-0.59
Free cash flow	$-34.01M	$-34.41M	$-32.46M	$-21.18M	$692000.00
Profit margin	-56.99%	-42.31%	-58.36%	-26.15%	-26.20%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
STIM	$117.59M	35	8.0	2.0	6.7	5.0	+86.24%	Hold
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Neuronetics Inc trades at $1.94. Our Smart Value Score of 35/100 indicates the stock is weak. TTM revenue stands at $149.16M. with profit margins at -26.20%. Our DCF model estimates intrinsic value at $13.08.

Frequently asked questions

What is Neuronetics Inc's stock price?

Neuronetics Inc (STIM) trades at $1.94.

Is Neuronetics Inc overvalued?

Smart Value Score 35/100 (Grade D, Sell). DCF value $13.08.

What is the price target of Neuronetics Inc (STIM)?

The analyst target price is $4.33, representing +123.4% upside from the current price of $1.94.

What is the intrinsic value of Neuronetics Inc (STIM)?

Based on our DCF model, intrinsic value is $13.08, a +86.2% margin of safety versus $1.94.

What is Neuronetics Inc's revenue?

TTM revenue is $149.16M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.79x

ROE-134.90%

Beta0.87

50D MA$1.41

200D MA$2.31

Shares out0.07B

Float0.03B

Short ratio—

Avg volume1.9M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

STIM vs LLY →STIM vs JNJ →STIM vs ABBV →Stock screener →